News
Nature Biotechnology 25, 609 - 610 (2007)
Published online: 1 June 2007 | doi:10.1038/nbt0607-609
Licensing deals morph to acquisitions in seller's market
Nuala Moran1
- London
Abstract
Pharma's pipeline problems, coupled with the trend toward acquisition, are giving biotechs more leverage in licensing discussions.
